Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Checkpoint Therapeutics Inc (CKPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Checkpoint Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments...

FBIO : 3.13 (-3.99%)
CKPT : 3.28 (-8.12%)
Why Checkpoint Therapeutics (CKPT) Might Be a Diamond in the Rough

Although overlooked by the investors, Checkpoint Therapeutics (CKPT) looks well positioned for a solid gain evident from its favorable Zacks rank and positive estimate revision.

CKPT : 3.28 (-8.12%)
Checkpoint Therapeutics Initiates Dose Expansion Portion of Phase 1 Trial of Anti-PD-L1 Antibody CK-301

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments...

FBIO : 3.13 (-3.99%)
CKPT : 3.28 (-8.12%)
Blog Exposure - Checkpoint Therapeutics to Present Preclinical Data on its BET Inhibitor CK-103 at AACR Meeting

Stock Monitor: Corvus Pharma Post Earnings Reporting

CKPT : 3.28 (-8.12%)
CRVS : 11.12 (+0.27%)
Checkpoint Therapeutics to Participate in March Investor Conferences

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments...

FBIO : 3.13 (-3.99%)
CKPT : 3.28 (-8.12%)
Checkpoint Therapeutics to Present at BIO CEO & Investor Conference

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that James F. Oliviero, President and Chief Executive Officer, will present a company...

FBIO : 3.13 (-3.99%)
CKPT : 3.28 (-8.12%)
Checkpoint Therapeutics to Present at Biotech Showcase(TM) 2018

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that President and Chief Executive Officer James F. Oliviero will present a company...

FBIO : 3.13 (-3.99%)
CKPT : 3.28 (-8.12%)
Checkpoint Therapeutics to Participate in LifeSci Advisors Corporate Access Event in San Francisco, January 8 - 10, 2018

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that its senior management team will host institutional investor and partnering meetings...

FBIO : 3.13 (-3.99%)
CKPT : 3.28 (-8.12%)
Checkpoint Therapeutics Initiates Phase 1 Study of Anti-PD-L1 Antibody CK-301

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that the first patient has been dosed in a Phase 1 clinical study evaluating the safety...

FBIO : 3.13 (-3.99%)
CKPT : 3.28 (-8.12%)
Checkpoint Therapeutics to Present at the Ladenburg Thalmann 2017 Healthcare Conference

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that James F. Oliviero, President and Chief Executive Officer of Checkpoint, will present...

FBIO : 3.13 (-3.99%)
CKPT : 3.28 (-8.12%)
Checkpoint Therapeutics Receives Orphan Drug Designation for CK-101 for the Treatment of EGFR Mutation-Positive Non-Small Cell Lung Cancer

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation...

FBIO : 3.13 (-3.99%)
CKPT : 3.28 (-8.12%)
Checkpoint Therapeutics to Present at the 19th Annual Rodman & Renshaw Global Investment Conference

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that James F. Oliviero, President and Chief Executive Officer of Checkpoint, will present...

FBIO : 3.13 (-3.99%)
CKPT : 3.28 (-8.12%)

Van Meerten Stock Picks

5 Great Growth Stocks
This morning I wanted to find 5 stocks that were predicted to have double digit growth in both Revenue and Earnings over the next 5 years that were also having great current performance.
LULU +1.14 , ABMD -1.06 , AAXN +2.28 , NSP +0.90 , ERI +1.00
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Brugler Ag Report

Today's Commentary

Corn futures were weak into the close on Thursday, down 3 to 4 1/4 cents lower in the front months. Traders were taking money off the table ahead of the extended weekend. The USDA reported a private cancelation of 132,000 of grain sorghum to unknown ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar